dm+d
427002003
Medicine Compliance Aid Stability
RasilezNoden Pharma DAC
Noden Pharma DAC
Rasilez
Tablets f/c 150mg, 300mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from moisture
Protect from moisture
12 January 2022
Lactation Safety Information
Alternative suitable antihypertensive
No published evidence of safety
Low levels anticipated in milk due to very low absorption by the mother
Monitor infant for hypotension, especially if premature or newborn
13 January 2017